GEN-SIRO

Sirolimus Stent

Sirolimus Eluting Coronary Stent System (Drug Eluting Stent)

ADVANTAGES

Unique stent design and strut locking mechanism offers excellent radial strength and minimum recoil
Completely biodegradable, biocompatible polymer (PLGA carrier) - Loading density of 1.35 μ/MM2
Inhibits In-stent restenosis (ISR) & late stent thrombosis with adequate re-endothelization
605 cobalt-chromium stent platform with open and closed cell design
Designed for utmost safety - Premier displays one of the lowest entry profiles
Uniform neointimal coverage and improved stent apposition
90% of sirolimus released within 90 to 120 days
Complete endothelialisation within 90 days
Hydrophilic coated stent delivery system

GET IN TOUCH

+61 402 558 996 | +61 424 872 657
51 Cheviot Drive, Truganina, Victoria 3029, Australia
admin@apexgen.com.au

The availability and indication claim(s) of the products displayed on APEXGEN websites may vary based on different markets. APEXGEN does not assume responsibility for any interactions or transactions conducted through this website that fail to adhere to the relevant laws and regulations of your jurisdiction. By continuing to use this website, you acknowledge and consent to the terms outlined in this notice.

Gen-Siro

Sirolimus Stent

ADVANTAGES

Unique stent design and strut locking mechanism offers excellent radial strength and minimum recoil

Completely biodegradable, biocompatible polymer (PLGA carrier) - Loading density of 1.35 μ/MM2

Inhibits In-stent restenosis (ISR) & late stent thrombosis with adequate re-endothelization

605 cobalt-chromium stent platform with open and closed cell design

Designed for utmost safety - Premier displays one of the lowest entry profiles

Uniform neointimal coverage and improved stent apposition

90% of sirolimus released within 90 to 120 days

Complete endothelialisation within 90 days

Hydrophilic coated stent delivery system

GET IN TOUCH

Follow Us